GON-injection for a Sooner and Better Treatment of Cluster Headache (CHIANTI)
GON-injection for a Sooner and Better Treatment of Cluster Headache: a Double-blind Randomized Controlled Trial
Sponsor: Innovatiefonds Zorgverzekeraars
A PHASE4 clinical study on Cluster Headache, Episodic and Greater Occipital Nerve Injection, this trial is completed. The trial is conducted by Innovatiefonds Zorgverzekeraars and has accumulated 8 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Apr 2024 — Jul 2024 [monthly]
Completed PHASE4
Status: Unknown Status → Completed
-
Nov 2021 — Apr 2024 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Oct 2021 — Nov 2021 [monthly]
Recruiting PHASE4
▶ Show 3 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Recruiting PHASE4
-
Nov 2019 — Jan 2021 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Aug 2019 — Nov 2019 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Innovatiefonds Zorgverzekeraars
- Leiden University Medical Center
- Netherlands Brain Foundation
For direct contact, visit the study record on ClinicalTrials.gov .